Gelatin and BSE Risk: Negligible with Proper Manufacturing

Gelatin is produced from collagen (bones, hides, tendons) via acid/alkali extraction, filtration, purification, and drying. Prions are not found in collagen-rich connective tissues used for gelatin.

Safety Evidence

  • Infectivity titers in bones/hides: extremely low/undetectable.
  • Manufacturing process (acid/alkali, heat, filtration) further reduces any theoretical risk.
  • WHO (1999), EU SSC (2000), FDA: gelatin safe regarding BSE.
  • No vCJD cases linked to gelatin.

Conditions for Safety

  • Source: BSE-negligible/controlled risk countries (OIE status).
  • Exclude SRMs (skull, vertebral column >30 mo).
  • Validated manufacturing (dedicated lines, no cross-contamination).
  • Reputable manufacturers with traceability.

Regulatory Status

  • EU: Gelatin from bovine bones/hides permitted with SRM exclusion and process validation.
  • US: FDA considers gelatin safe; no BSE-related restrictions.

Pharmaceutical/capsule gelatin undergoes even stricter purification.

Animal Bites - Related Articles